(Q28205919)

English

Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme

scientific article (publication date: May 2002)

Statements

Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme (English)
0 references
0 references
0 references
M Campone
0 references
B Coudert
0 references
M Van den Bent
0 references
M de Jonge
0 references
C Dittrich
0 references
R Rampling
0 references
R Sorio
0 references
D Lacombe
0 references
C de Balincourt
0 references
P Fumoleau
0 references
May 2002
0 references
13
0 references
5
0 references
777-80
0 references

Identifiers

0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit